市場データを読み込み中...
2026年8月29日土曜日
ホームへ戻るKorea StockHanmi Semiconductorの記事をすべて見る

Hanmi Semiconductor (042700.KS) FY2025 Financial Analysis: Cash Surges 166% as HBM Equipment Dominates

執筆 MinJeKim3 回閲覧

この記事の日本語訳は準備中です。以下は英語の原文です。

Hanmi Semiconductor (042700.KS) FY2025 Financial Analysis: Cash Surges 166% as HBM Equipment Dominates

Hanmi Semiconductor (042700.KS)

FY2025 Financial Analysis: Cash Surges 166% as HBM Equipment Dominates

Source: Hanmi Semiconductor Annual Report (46th FY) — Filed March 12, 2026 | Consolidated Financial Statements | Unit: KRW millions

Published: April 9, 2026 | By LineVest Editorial Team

Hanmi Semiconductor posted consolidated revenue of ₩576.7 billion in FY2025, up 3.2% year-on-year, as its HBM TC Bonder franchise continued to anchor demand from leading memory chipmakers. While top-line growth moderated from FY2024's explosive 251% surge, the company demonstrated exceptional cash generation, balance sheet strengthening, and margin resilience — cementing its position as one of Korea's premier semiconductor equipment makers.

📊 Key Financial Highlights at a Glance

MetricFY2023FY2024FY2025YoY Change
Revenue₩159.0B₩558.9B₩576.7B▲3.2%
Gross Profit₩79.4B₩314.5B₩332.0B▲5.6%
Gross Margin49.9%56.3%57.6%▲130bps
Operating Income₩56.7B₩255.5B₩251.4B▼1.6%
Operating Margin35.7%45.7%43.6%▼210bps
Net Income₩311.0B*₩152.7B₩214.0B▲40.2%
EPS (₩)₩3,216*₩1,589₩2,256▲42.0%
Cash & Equiv.₩179.7B₩104.0B₩276.2B▲165.6%

1. Revenue and Profitability

Revenue growth decelerated sharply to 3.2% following FY2024's 251% breakout year, driven by concentrated HBM TC Bonder orders. This normalization reflects a higher base effect rather than weakening demand — confirmed by robust advance receipts of ₩68.4B, a 3.6x increase year-over-year, signaling strong FY2026 order intake.

More telling is the gross margin expansion to 57.6%, the highest in the company's three-year history. This was achieved by optimizing the outsourcing mix: cutting external manufacturing by 48.6% while maintaining in-house efficiencies.

Operating income edged down 1.6% to ₩251.4B, with an operating margin of 43.6% versus 45.7% in FY2024. The culprit was a 36.1% surge in SG&A expenses to ₩80.6B, reflecting headcount growth, Singapore subsidiary establishment, and patent litigation costs.

Net income rebounded sharply to ₩214.0B (+40.2%), despite slightly lower operating earnings. The gap is explained by a ₩74.5B swing in non-operating income — driven by a ₩73.8B gain from cancellation of treasury shares.

Margin Analysis

MarginFY2023FY2024FY2025
Gross Margin49.9%56.3%57.6%
Operating Margin35.7%45.7%43.6%
Net Margin195.6%*27.3%37.1%

* FY2023 net margin distorted by ~₩207.1B one-off financial asset valuation gains.

2. Cost Structure: Fixed vs. Variable

Total operating costs reached ₩325.3B. The cost base is split across three categories:

Cost TypeFY2025 (₩B)YoY ChangeKey Driver
Fixed Costs (COGS)₩201.0B▼1.0%In-house manufacturing stable
Semi-Variable Costs (SG&A)₩80.6B▲36.1%Headcount, Singapore subsidiary, legal
Variable Costs (Outsourcing)₩43.7B▼4.2%Outsourcing cut by 48.6%

The most notable shift was in semi-variable costs, which surged 119% to ₩39.2B. Service fees alone jumped 61.9% to ₩23.9B, reflecting expanded global sales infrastructure including a new Singapore subsidiary. Variable costs fell 4.2% as outsourcing was cut by nearly half (-48.6%) — the primary driver of gross margin improvement.

3. Balance Sheet: Debt-Free, Cash-Rich

ItemFY2025FY2024FY2023
Cash & Equivalents₩276.2B₩104.0B₩179.7B
Accounts Receivable₩62.4B₩146.9B₩40.6B
Inventory₩150.4B₩153.4B₩95.4B
PP&E & Inv. Property₩246.9B₩183.7B₩135.7B
Intangible Assets₩23.3B₩4.6B₩4.5B
Total Assets₩813.3B₩710.9B₩726.9B
Short-term Borrowings₩0B₩0B₩0B
Total Equity₩694.3B₩618.7B₩677.3B

Total assets grew to ₩813.3B on the back of a 166% surge in cash to ₩276.2B — a record high. With zero borrowings at year-end, the company carries no financial debt, giving it maximum flexibility for capital allocation. Advance receipts of ₩68.4B confirm robust order visibility heading into FY2026.

4. Cash Flow Analysis

CF CategoryFY2025 (₩B)FY2024 (₩B)FY2023 (₩B)
Operating CF₩228.6B₩152.9B₩43.8B
Investing CF+₩18.3B-₩86.1B-₩36.8B
Financing CF-₩77.2B-₩231.7B-₩24.1B
Net Change in Cash+₩172.2B-₩164.9B-₩17.1B

Operating CF hit ₩228.6B — more than five times FY2023's level — driven by ₩85.4B in accounts receivable collections and ₩37.9B in inventory optimization. This reflects the high cash conversion quality of Hanmi's business model.

Investing CF turned positive at +₩18.3B, but this masks an acceleration in capital investment. CAPEX jumped 39.4% to ₩74.5B — directed at new equipment lines and intangible asset development (up ₩19.1B) — while financial asset disposals generated ₩112.4B in inflows.

Financing outflows contracted sharply from ₩231.7B to ₩77.2B. Share buybacks were scaled back to ₩7.8B (vs. ₩189.9B in FY2024) while dividends were raised 68.5% to ₩68.3B. Prior period buybacks totaling ₩130.3B in treasury shares were cancelled, delivering permanent per-share value accretion.

5. Key Takeaways and Outlook

Hanmi Semiconductor enters FY2026 in its strongest financial position to date — debt-free, with record cash, industry-leading margins, and an expanding product portfolio targeting HBM6, 2.5D AI packaging, and hybrid bonding platforms.

Key Risks

  • Customer concentration — SK Hynix dependency remains the central demand risk
  • SG&A creep — a 36% cost increase against only 3% revenue growth compresses operating leverage
  • WIDE TC Bonder ramp timing — commercialization delay would affect FY2026 order momentum

Upside Drivers

  • Advance receipts up 3.6x signal strong order intake heading into FY2026
  • Intangible investment surge (₩19.1B) reflects pipeline breadth across hybrid bonder and 2.5D packaging
  • Zero-debt balance sheet with record ₩276.2B cash provides full flexibility for accelerated R&D or M&A
  • EPS of ₩2,256 in FY2025 (+42.0% YoY) reflects strong per-share earnings growth
DimensionAssessmentSignal
Revenue QualityHigh — HBM-linked, advance-receipt backed🟢 Strong
Margin ProfileBest-in-class at 57.6% gross, 43.6% operating🟢 Strong
Balance SheetZero debt, record ₩276B cash🟢 Strong
Cash ConversionOperating CF / Net Income = 106.8%🟢 Strong
Cost DisciplineSG&A +36% vs. Revenue +3%🟡 Watch
Customer RiskConcentrated in SK Hynix🟡 Watch

Disclaimer: This report is for informational purposes only and does not constitute investment advice. All figures sourced from publicly disclosed financial statements. Past performance is not indicative of future results.

見出しの先を読む

何が起きたかは読みました。次は、それが何を意味するかを。

無料デイリーブリーフィング

米国市場を毎朝 — 無料で

LineVest Dailyが寄付き前に届きます:米国市場の主要ストーリー、決算、開示、外国人フロー — わかりやすい英語で。無料、カード登録不要。

LineVest Dailyを無料で →
この企業

Hanmi Semiconductorの詳細レポート

Hanmi Semiconductorの最新SEC開示を全て読み込みます — US GAAPの財務、ガバナンス、株価への意味まで。3時間以内にPDFでお届け。

$12・買い切り

Hanmi Semiconductorレポートを入手
ウォッチ銘柄すべて

市場全体をフォロー

週に何銘柄も米国株を見ていますか?すべての分析記事を公開と同時に — デイリーの米国市場全カバレッジと90日アーカイブ。

$9.99・月額

購読する

一次資料のSEC開示に基づく独立ジャーナリズム — 投資助言ではありません。証券会社との提携はありません。

関連記事

How to Read Korean DART Filings in English: A Guide for Foreign Investors
企業分析

How to Read Korean DART Filings in English: A Guide for Foreign Investors

サムスン電子(005930.KS)2026年Q2:営業利益89.5兆ウォンで過去最高、MXは2011年以来初の四半期赤字
企業分析

サムスン電子(005930.KS)2026年Q2:営業利益89.5兆ウォンで過去最高、MXは2011年以来初の四半期赤字

セルトリオン、2026年Q2決算を修正開示――営業利益4,300億ウォンの過去最高を確認
企業分析

セルトリオン、2026年Q2決算を修正開示――営業利益4,300億ウォンの過去最高を確認

企業分析

ABLバイオ(298380.KQ)2026年第1四半期:損失48%縮小、現金₩1,867億保有

EOテクニクス (039030.KQ) 2026年1Q:HBMレーザー需要急増で営業利益が倍増
企業分析

EOテクニクス (039030.KQ) 2026年1Q:HBMレーザー需要急増で営業利益が倍増

三千堂製薬(000250.KS)FY2025:アイリアバイオシミラー発売が牽引、営業利益220%急増・最終黒字転換
企業分析

三千堂製薬(000250.KS)FY2025:アイリアバイオシミラー発売が牽引、営業利益220%急増・最終黒字転換

OCIホールディングス(010060.KS)2026年Q2:テキサス太陽光が牽引し売上高58%増・3四半期連続黒字
企業分析

OCIホールディングス(010060.KS)2026年Q2:テキサス太陽光が牽引し売上高58%増・3四半期連続黒字

コーロン・ティッシュジーン(950160.KQ)2026年Q1:純損失₩99.9BのうちTG-C第3相主要エンドポイント未達で95%が非現金デリバティブ
企業分析

コーロン・ティッシュジーン(950160.KQ)2026年Q1:純損失₩99.9BのうちTG-C第3相主要エンドポイント未達で95%が非現金デリバティブ

ジュソン・エンジニアリング(036930.KQ)2026年Q1:売上高54.9億ウォンへ半減、R&D費が売上の46%に達し営業損失70億ウォン
企業分析

ジュソン・エンジニアリング(036930.KQ)2026年Q1:売上高54.9億ウォンへ半減、R&D費が売上の46%に達し営業損失70億ウォン

レインボーロボティクス(277810.KQ)2026年第1四半期:サムスン電子の支援で売上高116.6%急増、研究開発費の重さで営業損失が拡大
企業分析

レインボーロボティクス(277810.KQ)2026年第1四半期:サムスン電子の支援で売上高116.6%急増、研究開発費の重さで営業損失が拡大

アルテオジェン(196170.KQ)2026年Q1:販管費120%急増で営業利益36%減、₩8,675億バイオジェン契約を締結
企業分析

アルテオジェン(196170.KQ)2026年Q1:販管費120%急増で営業利益36%減、₩8,675億バイオジェン契約を締結

エコプロ (086520.KQ) 2026年1Q:₩247.3Bの損益転換、粗利益率が2倍に
企業分析

エコプロ (086520.KQ) 2026年1Q:₩247.3Bの損益転換、粗利益率が2倍に